Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.00M | -276.00M | -34.00M | 11.00M | 67.00M |
| Total Depreciation and Amortization | 166.00M | 168.00M | 168.00M | 161.00M | 152.00M |
| Total Amortization of Deferred Charges | 6.00M | 6.00M | 8.00M | 8.00M | 9.00M |
| Total Other Non-Cash Items | 47.00M | -15.00M | 18.00M | 5.00M | 5.00M |
| Change in Net Operating Assets | -263.00M | 225.00M | 59.00M | 52.00M | -237.00M |
| Cash from Operations | 13.00M | 108.00M | 219.00M | 237.00M | -4.00M |
| Capital Expenditure | -51.00M | -62.00M | -92.00M | -57.00M | -65.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 0.00 | 0.00 | 0.00 | 9.00M |
| Other Investing Activities | -9.00M | -2.00M | -9.00M | 1.00M | -2.00M |
| Cash from Investing | -60.00M | -64.00M | -101.00M | -56.00M | -58.00M |
| Total Debt Issued | -- | 2.11B | 290.00M | 0.00 | 250.00M |
| Total Debt Repaid | -16.00M | -2.11B | -188.00M | -446.00M | -178.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -34.00M | -- | -- | -- | -13.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.00M | -17.00M | -255.00M | 290.00M | -7.00M |
| Cash from Financing | -65.00M | -18.00M | -153.00M | -156.00M | 52.00M |
| Foreign Exchange rate Adjustments | -5.00M | 14.00M | 1.00M | 27.00M | 29.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.00M | 40.00M | -34.00M | 52.00M | 19.00M |